Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05805358
PHASE2

Hyperpolarized 13C MRI for Cancer Immunotherapy

Sponsor: Chang Gung Memorial Hospital

View on ClinicalTrials.gov

Summary

The investigators aim to develop an advanced imaging platform, such as dynamic nuclear polarization (DNP) 13C-MRI, MR fingerprinting (MRF) and MR Relaxometry, which combines with traditional anatomical contrast CT, MRI and PET, and integrate blood/urine metabolomics methods. A comprehensive strategy to thoroughly analyze the immune activation of spleen pattern, microstructure, cell density, red blood cell iron content, immune cell glycolysis and metabolic flow rate.

Official title: Next Generation Precision Imaging for Cancer Immunotherapy: Dynamic Nuclear Polarization and Metabolomics Study

Key Details

Gender

FEMALE

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2023-11-01

Completion Date

2026-07-31

Last Updated

2023-08-30

Healthy Volunteers

No

Interventions

DRUG

Hyperpolarized 13C-Pyruvate injection

DNP-MRI for splenic immune function evaluation through hyperpolarized 13C-Pyruvate injection

Locations (1)

Chang Gung Memorial Hospital

Taoyuan, Guishan District, Taiwan